The selection of aptamers specific for membrane molecular targets

[1] Yarus, M. Life from an RNA World: the ancestor within. Harvard University Press, New York, 2010. Search in Google Scholar

[2] Connell, G.J., Illangsekare, M., Yarus, M. Three small ribooligonucleotides with specific arginine sites. Biochemistry 32 (1993) 5497–5502. http://dx.doi.org/10.1021/bi00072a00210.1021/bi00072a002Search in Google Scholar PubMed

[3] Khvorova, A., Kwak, Y.-G., Tamkun, M., Majerfeld, I. and Yarus, M. RNAs that bind and change the permeability of phospholipid membranes. Proc. Natl. Acad. Sci. USA 96 (1999) 10649–10654. http://dx.doi.org/10.1073/pnas.96.19.1064910.1073/pnas.96.19.10649Search in Google Scholar PubMed PubMed Central

[4] Yarus, M. A specific amino acid binding site composed of RNA. Science 240 (1988) 1751–1758. http://dx.doi.org/10.1126/science.338109910.1126/science.3381099Search in Google Scholar PubMed

[5] Roth, A., Winkler, W.C., Regulski, E.E., Lee, B.W.K., Lim, J., Jona, I., Barrick, J.E., Ritwik, A., Kim, J.N., Welz, R., Iwata-Reuyl, D. and Breaker, R.R. A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain. Nat. Struct. Mol. Biol. 14 (2007) 308–317. http://dx.doi.org/10.1038/nsmb122410.1038/nsmb1224Search in Google Scholar PubMed

[6] Spitale, R.C., Terelli, A.T., Krucinska, J., Bandarlan, V., Wedekind, J.E. The structural basis for recognition of the preQ0 metabolite by an unusually small riboswitch aptamer domain. J. Biol. Chem. 284 (2009) 11012–11016. http://dx.doi.org/10.1074/jbc.C90002420010.1074/jbc.C900024200Search in Google Scholar PubMed PubMed Central

[7] Ellington, A.D. and Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818–822. http://dx.doi.org/10.1038/346818a010.1038/346818a0Search in Google Scholar PubMed

[8] Tuerk, C. and Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA-polymerase. Science 249 (1990) 505–510. http://dx.doi.org/10.1126/science.220012110.1126/science.2200121Search in Google Scholar PubMed

[9] Janas, T., Widmann, J.J., Knight, R. and Yarus, M. Simple, recurrent RNA binding sites for L-arginine. RNA (2010) 805–816. 10.1261/rna.1979410Search in Google Scholar PubMed PubMed Central

[10] Bock, L.C., Griffin, L.C., Latham, J.A., Vermaas, E.H. and Toole, J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355 (1992) 564–566. http://dx.doi.org/10.1038/355564a010.1038/355564a0Search in Google Scholar PubMed

[11] Anderson, P.C. and Mecozzi, S. Unusually short RNA sequences: design of a 13-mer RNA that selectively binds and recognizes theophylline. J. Am. Chem. Soc. 127 (2005) 5290–5291. http://dx.doi.org/10.1021/ja043246310.1021/ja0432463Search in Google Scholar PubMed

[12] Farokhzad, O.C., Cheng, J., Teply, B.A., Sherifi, I., Jon, S., Kantoff, P.W., Richie, J.P. and Langer, R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 103 (2006) 6315–6320. http://dx.doi.org/10.1073/pnas.060175510310.1073/pnas.0601755103Search in Google Scholar PubMed PubMed Central

[13] Song, S., Wang, L., Li, J., Zhao, J. and Fan, C. Aptamer-based biosensors. Trends Anal. Chem. 27 (2008) 108–117. http://dx.doi.org/10.1016/j.trac.2007.12.00410.1016/j.trac.2007.12.004Search in Google Scholar

[14] Lee, J.O., So, H.M., Jeon, E.K., Chang, H., Won, K. and Kim, Y.H. Aptamers as molecular recognition elements for electrical nanobiosensors. Anal. Bioanal. Chem. 390 (2008) 1023–1032. http://dx.doi.org/10.1007/s00216-007-1643-y10.1007/s00216-007-1643-ySearch in Google Scholar PubMed PubMed Central

[15] Barbas, A.S. and White, R.R. The development and testing for cancer. Curr. Opin. Investig. Drugs 10 (2009) 572–578. Search in Google Scholar

[16] Hicke, B.J., Marion, C., Chang, Y.F., Gould, T., Lynott, C.K., Parma, D., Schmidt, P.G. and Warren, S. Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 276 (2001) 48644–48654. http://dx.doi.org/10.1074/jbc.M10465120010.1074/jbc.M104651200Search in Google Scholar PubMed

[17] Pestourie, C. Tavitian, B. and Duconge, F. Aptamets against extracellular targets for in vivo applications. Biochimie 87 (2005) 921–930. http://dx.doi.org/10.1016/j.biochi.2005.04.01310.1016/j.biochi.2005.04.013Search in Google Scholar PubMed

[18] Janas, T., Janas, T. and Yarus, M. RNA, lipids and membranes. in: The RNA World III (Gesteland,, R., Cech, T.R. and Atkins, J., Eds.), Cold Spring Harbor Laboratory Press, 2006, 207–225. Search in Google Scholar

[19] Shamah, S.M., Healy, J.M. and Cload, S.T. Complex target SELEX. Acc. Chem. Res. 41 (2008) 130–138. http://dx.doi.org/10.1021/ar700142z10.1021/ar700142zSearch in Google Scholar PubMed

[20] Li, N., Ebright, J.N., Stovall, G.M., Chen, X., Nguyen, H.H., Singh, A., Syrett, A. and Ellington, A.D. Technical and biological issues relevant to cell typing with aptamers. J. Proteome Res. 8 (2009) 2438–2448. http://dx.doi.org/10.1021/pr801048z10.1021/pr801048zSearch in Google Scholar PubMed

[21] Lupold, S.E., Hicke, B.J., Lin, Y. and Coffey, D.S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62 (2002) 4029–4033. Search in Google Scholar

[22] Chen, C.h.B., Chernis, G.A., Hoang, V.Q. and Landgraf, R. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc. Natl. Acad. Sci. USA 100 (2003) 9226–9231. http://dx.doi.org/10.1073/pnas.133266010010.1073/pnas.1332660100Search in Google Scholar PubMed PubMed Central

[23] Rentmeister, A., Bill, A., Wahle, T., Walter, J. and Famulok, M. RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of β-secretase BACE1 in vitro. RNA 12 (2006) 1650–1660. http://dx.doi.org/10.1261/rna.12630610.1261/rna.126306Search in Google Scholar PubMed PubMed Central

[24] O’Connell, D., Koenig, A., Jennings, S., Hicke, B., Han, H.L., Fitzwater, T., Chang, Y.F., Varki, N., Parma, D. and Varki, A. Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc. Natl. Acad. Sci. USA 93 (1996) 5883–5887. http://dx.doi.org/10.1073/pnas.93.12.588310.1073/pnas.93.12.5883Search in Google Scholar PubMed PubMed Central

[25] Lee, H.K., Choi, Y.S., Park, Y.A. and Jeong, S. Modulation of oncogenic transcription and alternative splicing by β-catenin and an RNA aptamer in colon cancer cells. Cancer Res. 66 (2006) 10560–10566. http://dx.doi.org/10.1158/0008-5472.CAN-06-252610.1158/0008-5472.CAN-06-2526Search in Google Scholar PubMed

[26] Tanaka, Y., Akagi, K., Nakamura, Y. and Kozu, T. RNA aptamers targeting the carboxyl terminus of KRAS oncoprotein generated by an improved SELEX with isothermal RNA amplification. Oligonucleotides 17 (2007) 12–21. http://dx.doi.org/10.1089/oli.2006.0035R110.1089/oli.2006.0035R1Search in Google Scholar PubMed

[27] Jeon, S.H., Kayhan, B., Ben-Yedidia, T. and Arnon, R. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J. Biol. Chem. 279 (2004) 48410–48419. http://dx.doi.org/10.1074/jbc.M40905920010.1074/jbc.M409059200Search in Google Scholar PubMed

[28] Ferreira, C.S.M., Matthews, C.S. and Missailidis, S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumor Biol. 27 (2006) 289–301. http://dx.doi.org/10.1159/00009608510.1159/000096085Search in Google Scholar PubMed

[29] Daniels, D.A., Sohal, A.K., Rees, S. and Grisshammer, R. Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. Anal. Biochem. 305 (2002) 214–226. http://dx.doi.org/10.1006/abio.2002.566310.1006/abio.2002.5663Search in Google Scholar PubMed

[30] Joshi, R., Janagama, H., Dwivedi, H.P., Kumar, T.M.A.S., Jaykus, L.A. Schefers, J. and Sreevatsan, S. Selection, characterization, and application of DNA aptamers for the capture and detection of Salmonella enterica serovars. Mol. Cell. Probes 23 (2009) 20–28. http://dx.doi.org/10.1016/j.mcp.2008.10.00610.1016/j.mcp.2008.10.006Search in Google Scholar PubMed

[31] Ulrich, H., Ippolito, J.E., Pagan, O.R., Eterovic, V.A., Hann, R.M., Shi, H., Lis, J.T., Eldefrawi, M.E. and Hess, G.P. In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 95 (1998) 14051–14056. http://dx.doi.org/10.1073/pnas.95.24.1405110.1073/pnas.95.24.14051Search in Google Scholar PubMed PubMed Central

[32] Morris, K.N., Jensen, K.B., Julin, C.M., Weil, M. and Gold, L. High affinity ligands from in vitro selection: complex target. Proc. Natl. Acad. Sci. USA 95 (1998) 2902–2907. http://dx.doi.org/10.1073/pnas.95.6.290210.1073/pnas.95.6.2902Search in Google Scholar PubMed PubMed Central

[33] Shangguan, D., Li, Y., Tang, Z., Cao, Z.C., Chen, H.W., Mallikaratchy, P., Sefah, K., Yang, C.J. and Tan, W. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. USA 103 (2006) 11838–11843. http://dx.doi.org/10.1073/pnas.060261510310.1073/pnas.0602615103Search in Google Scholar PubMed PubMed Central

[34] Homann, M. and Göringer, H.U. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 27 (1999) 2006–2014. http://dx.doi.org/10.1093/nar/27.9.200610.1093/nar/27.9.2006Search in Google Scholar PubMed PubMed Central

[35] Blank, M., Weinschenk, T., Priemer, M. and Schluesener, H. Systematic evolution of DNA aptamer binding to rat brain tumor microvessels. J. Biol. Chem. 276 (2001) 16464–16468. http://dx.doi.org/10.1074/jbc.M10034720010.1074/jbc.M100347200Search in Google Scholar PubMed

[36] Mallikaratchy, P., Tang, Z., Kwame, S., Meng, L., Shangguan, D. and Tan, W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt’s lymphoma cells. Mol. Cell. Proteomics 6 (2007) 2230–2238. http://dx.doi.org/10.1074/mcp.M700026-MCP20010.1074/mcp.M700026-MCP200Search in Google Scholar PubMed

[37] Shangguan, D., Cao, Z., Meng, L., Mallikaratchy, P., Sefah, K., Wang, H., Li, Y. and Tan, W. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. Proteome Res. 7 (2008) 2133–2139. http://dx.doi.org/10.1021/pr700894d10.1021/pr700894dSearch in Google Scholar PubMed PubMed Central

[38] Berezovski, M.V., Lechmann, M., Musheev, M.U., Mak, T.W. and Krylov, S.N. Aptamer-facilitated biomarker discovery (AptaBiD). J. Am. Chem. Soc. 130 (2008) 9137–9143. http://dx.doi.org/10.1021/ja801951p10.1021/ja801951pSearch in Google Scholar PubMed

[39] Ulrich, H., Magdesian, M.H., Alves, M.J.M. and Colli, W. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J. Biol. Chem. 277 (2002) 20756–20762. http://dx.doi.org/10.1074/jbc.M11185920010.1074/jbc.M111859200Search in Google Scholar PubMed

[40] Cerchia, L., Duconge, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V. and Libri, D. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLOS Biol. 3 (2005) 697–704. http://dx.doi.org/10.1371/journal.pbio.003012310.1371/journal.pbio.0030123Search in Google Scholar PubMed PubMed Central

[41] Gopinath, S.C.B., Misono, T.S., Kawasaki, K., Mizuno, T., Imai, M., Odegiri, T. and Kumar, P.K.R. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J. Gen. Virol. 87 (2006) 479–487. http://dx.doi.org/10.1099/vir.0.81508-010.1099/vir.0.81508-0Search in Google Scholar PubMed

[42] Ohuchi, S.P., Ohtsu, T. and Nakamura, Y. Selection of RNA aptamers against recombinant transforming growth factor-β type III receptor displayed on cell surface. Biochimie 88 (2006) 897–904. http://dx.doi.org/10.1016/j.biochi.2006.02.00410.1016/j.biochi.2006.02.004Search in Google Scholar PubMed

[43] Sazani, P.L., Larraide, R. and Szostak, J.W. A small aptamer with strong and specific recognition of the triphosphate of ATP. J. Am. Chem Soc. 126 (2004) 8370–8371. http://dx.doi.org/10.1021/ja049171k10.1021/ja049171kSearch in Google Scholar PubMed PubMed Central

[44] Zimmerman, G.R, Jenison, R.D., Wick, C.L., Simorre, J.P. and Pardi, A. Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA. Nat. Struct. Biol. 4 (1997) 644–649. http://dx.doi.org/10.1038/nsb0897-64410.1038/nsb0897-644Search in Google Scholar PubMed

[45] Majerfeld, I. and Yarus, M. An RNA pocker for an aliphatic hydrophobe. Nature Struct. Biol. 1 (1994) 287–292. http://dx.doi.org/10.1038/nsb0594-28710.1038/nsb0594-287Search in Google Scholar

[46] Majerfeld, I. and Yarus, M. Isoleucine:RNA sites with associated coding sequences. RNA 4 (1998) 471–478. Search in Google Scholar

[47] Gilbert, B.A., Sha, M., Wathen, S.T. and Rando, R.R. RNA aptamers that specifically bind to a K Ras-derived farnesylated peptide. Bioorg. Med. Chem. 5 (1997) 1115–1122. http://dx.doi.org/10.1016/S0968-0896(97)00047-310.1016/S0968-0896(97)00047-3Search in Google Scholar

[48] Sussman, D., Nix, J.C. and Wilson, C. The structural basis for molecular recognition by the vitamin B12 RNA aptamer. Nat. Struct. Biol. 7 (2000) 53–57. http://dx.doi.org/10.1038/7125310.1038/71253Search in Google Scholar PubMed

[49] Illangasekare, M. and Yarus, M. Phenylalanine-binding RNAs and genetic code evolution. J. Mol. Evol. 54 (2002) 298–311. Search in Google Scholar

[50] Betat, H., Vogel, S., Struhalla, M., Förster, H.H., Famulok, M., Welzel, P. and Hahn, U. Aptamers that recognize the lipid moiety of the antibiotic moenomycin A. Biol. Chem. 384 (2003) 1497–1500. http://dx.doi.org/10.1515/BC.2003.16510.1515/BC.2003.165Search in Google Scholar PubMed

[51] Brockstedt, U., Uzarowska, A., Montpetit, A., Pfau, W. and Labuda, D. In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. Biochem. Biophys. Res Commun. 313 (2004) 1004–1008. http://dx.doi.org/10.1016/j.bbrc.2003.12.03010.1016/j.bbrc.2003.12.030Search in Google Scholar PubMed

[52] Janas, T., Janas, T. and Yarus, M. Specific RNA binding to ordered phospholipid bilayers. Nucleic Acids Res. 34 (2006) 2128–2136. http://dx.doi.org/10.1093/nar/gkl22010.1093/nar/gkl220Search in Google Scholar PubMed PubMed Central

[53] Vlassov, A., Khvorova, A., and Yarus, M. Binding and disruption of phosholipid bilayers by supramolecular RNA complexes. Proc. Natl. Acad. Sci. USA 98 (2001) 7706–7711. http://dx.doi.org/10.1073/pnas.14104109810.1073/pnas.141041098Search in Google Scholar PubMed PubMed Central

[54] Janas, T. and Yarus, M. Visualization of membrane RNAs. RNA 9 (2003) 1353–1361. http://dx.doi.org/10.1261/rna.512980310.1261/rna.5129803Search in Google Scholar PubMed PubMed Central

[55] Janas, T., Janas, T. and Yarus, M. A membrane transporter for tryptophan composed of RNA. RNA 10 (2004) 1541–1549. http://dx.doi.org/10.1261/rna.711270410.1261/rna.7112704Search in Google Scholar PubMed PubMed Central

[56] Janas, T. and Janas, T. A Search for membrane RNAs that can inhibit formation of toxic amyloid aggregates. Sie Foundation Symposium, Aurora, 2006, 13. Search in Google Scholar